WARRINGTON, Pa., June 17, 2010 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced that it has priced an underwritten public offering of 35,714,286 units at a price to the public of $0.28 per unit for gross proceeds of $10.0 million. Each unit consists of (i) one share of common stock, (ii) a five-year warrant to purchase 0.50 of a share of common stock and (iii) a short-term warrant to purchase 0.50 of a share of common stock. The shares of common stock and warrants are immediately separable and will be issued separately such that no units will be issued. The five-year warrants are exercisable immediately upon issuance, have a five-year term and an exercise price of $0.40 per share. The short-term warrants are exercisable immediately upon issuance, have a nine-month term and an exercise price of $0.28 per share. Net proceeds, after estimated underwriting discount and other estimated fees and expenses payable by Discovery Labs, and assuming the warrants are not exercised, will be approximately $9.1 million. The offering is expected to close on or about June 22, 2010, subject to satisfaction of customary closing conditions.
